human recombinant il-2 ( biogen ) was given intraperitoneally at doses ranging from 5,000 to 30,000 u , three times a day for 5 or 11-13 consecutive days beginning on day 10 after tumor implantation .
C0086418
human
C0021756
recombinant il-2